Header cover image

U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Results

605

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

605 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
QGEN
Qiagen		US$40.08-8.6%-11.1%US$8.9bUS$50.82PE103.6xE33.7%3.1%
AMLX
Amylyx Pharmaceuticals		US$3.749.4%-77.0%US$258.7mUS$8.00PS1.3xE38.3%n/a
KYTX
Kyverna Therapeutics		US$3.01-2.9%-89.9%US$129.5mUS$23.50PB0.4xE-19.7%n/a
BRNS
Barinthus Biotherapeutics		US$1.011.5%-60.3%US$41.4mUS$4.50PS2.7xE-1.8%n/a
MURA
Mural Oncology		US$4.2816.9%-8.7%US$76.3mUS$16.25PB0.4xE37.8%n/a
VSTM
Verastem		US$5.70-0.2%-51.9%US$265.9mUS$12.57PS26.2xE45.0%n/a
RNXT
RenovoRx		US$1.15-16.1%-25.3%US$27.9mUS$5.50PB3.9xE63.5%n/a
PMCB
PharmaCyte Biotech		US$1.55-1.9%-28.6%US$10.4mn/aPE1.1xn/an/a
PCRX
Pacira BioSciences		US$26.101.4%-13.1%US$1.2bUS$27.14PS1.7xE55.2%n/a
DRMA
Dermata Therapeutics		US$1.12-8.9%-83.2%US$2.3mUS$6.00PB0.5xE-14.0%n/a
SEPN
Septerna		US$13.17-15.6%n/aUS$581.2mUS$43.67PS596.1xE-60.2%n/a
NTRB
Nutriband		US$7.15-2.9%176.1%US$86.7mUS$13.00PS39.3xE94.3%n/a
SAVA
Cassava Sciences		US$2.32-1.7%-90.7%US$109.2mn/aPB0.7xE58.3%n/a
VNDA
Vanda Pharmaceuticals		US$4.627.2%6.7%US$279.9mUS$12.17PS1.4xE95.9%n/a
NRIX
Nurix Therapeutics		US$18.01-5.0%92.2%US$1.4bUS$32.28PS25.1xE3.7%n/a
CNTX
Context Therapeutics		US$0.84-4.0%-26.6%US$78.3mUS$7.08PB0.9xE-7.2%n/a
ALDX
Aldeyra Therapeutics		US$5.9915.9%76.7%US$353.1mUS$10.00PB4.2xE60.0%n/a
ALVR
AlloVir		US$9.71-0.9%-39.9%US$50.0mUS$34.50PB0.4xn/an/a
HLVX
HilleVax		US$1.82-4.7%-88.3%US$89.7mUS$3.00PB0.5xE13.7%n/a
BOLD
Boundless Bio		US$2.261.3%n/aUS$49.5mUS$14.50PB0.3xE-21.5%n/a
VYGR
Voyager Therapeutics		US$5.32-0.2%-30.8%US$296.1mUS$17.10PE11.2xE-25.7%n/a
SLN
Silence Therapeutics		US$4.92-2.8%-78.4%US$236.5mUS$53.70PS11.6xE6.8%n/a
KOD
Kodiak Sciences		US$5.34-8.2%-1.3%US$282.5mUS$6.67PB1.5xE1.8%n/a
MNPR
Monopar Therapeutics		US$51.8919.2%3,035.3%US$295.5mUS$52.25PB64xE28.4%n/a
Page 1 of 26